Luspatercept in Patients Affected With Rare Inherited Anemias
NCT07331818
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
45
Enrollment
OTHER
Sponsor class
Conditions
Hereditary Red Blood Cell Disorder (Disorder)
Interventions
DRUG:
Reblozyl
Sponsor
EuroBloodNet Association